Sentence: After surgery , 1,384 patients were randomly assigned to receive epirubicin plus cyclophosphamide ( EC ; 90 and 600 mg/m(2 ) , respectively , × four cycles ) , followed by docetaxel ( 100 mg/m(2 ) × four cycles ; EC-T ) or epirubicin plus docetaxel ( ET ; 90 and 75 mg/m(2 ) , respectively , × four cycles ) , followed by capecitabine ( 1,250 mg/m(2 ) twice a day on days 1 to 14 , × four cycles ; ET-X ) ; all regimens were given every 3 weeks .
Drug combination annotation:
[{'class': 'POS', 'spans': ['epirubicin', 'cyclophosphamide', 'docetaxel'], 'is_context_needed': True}, {'class': 'NEG', 'spans': [3, 4, 5], 'is_context_needed': True}]